Cargando…
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
We have previously shown that the Outer surface protein A (OspA) based Lyme borreliosis vaccine VLA15 induces protective immunity in mice. Herein, we report the induction of protective immunity by VLA15 with mouse models using ticks infected with B. burgdorferi (OspA serotype 1), B. afzelii (OspA se...
Autores principales: | Comstedt, Pär, Schüler, Wolfgang, Meinke, Andreas, Lundberg, Urban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581183/ https://www.ncbi.nlm.nih.gov/pubmed/28863166 http://dx.doi.org/10.1371/journal.pone.0184357 |
Ejemplares similares
-
Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis
por: Comstedt, Pär, et al.
Publicado: (2014) -
Borrelia burgdorferi OspA is an arthropod-specific transmission- blocking Lyme disease vaccine
Publicado: (1996) -
Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model
por: Schwendinger, Michael G., et al.
Publicado: (2013) -
OspA heterogeneity of Borrelia valaisiana confirmed by phenotypic and genotypic analyses
por: Ryffel, Karine, et al.
Publicado: (2003) -
The year that shaped the outcome of the OspA vaccine for human Lyme disease
por: Dattwyler, Raymond J., et al.
Publicado: (2022)